Vimarsana
Biggest News Aggregation in the World

Page 17 - Paces Advisors News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Paces Advisors. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Paces Advisors Today - Breaking & Trending Today

iShares 7-10 Year Treasury Bond ETF (NASDAQ:IEF) Sees Large Decline in Short Interest - Vimarsana News

iShares 7-10 Year Treasury Bond ETF (NASDAQ:IEF) Sees Large Decline in Short Interest

IShares 7-10 Year Treasury Bond ETF (NASDAQ:IEF – Get Free Report) saw a significant decrease in short interest in December. As of December 15th, there was short interest totalling 18,350,000 shares, a decrease of 12.7% from the November 30th total of 21,020,000 shares. Based on an average daily volume of 12,945,300 shares, the short-interest ratio […]

Hoylecohen LLC Raises Stake in Novo Nordisk A/S (NYSE:NVO) - Vimarsana News

Hoylecohen LLC Raises Stake in Novo Nordisk A/S (NYSE:NVO)

Hoylecohen LLC increased its stake in Novo Nordisk A/S (NYSE:NVO – Free Report) by 11.1% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 9,220 shares of the company’s stock after purchasing an additional 920 shares during the quarter. Hoylecohen LLC’s holdings in […]

NXP Semiconductors (NASDAQ:NXPI) Rating Increased to Buy at StockNews.com - Vimarsana News

NXP Semiconductors (NASDAQ:NXPI) Rating Increased to Buy at StockNews.com

StockNews.com upgraded shares of NXP Semiconductors (NASDAQ:NXPI – Free Report) from a hold rating to a buy rating in a research note released on Tuesday morning. A number of other analysts also recently issued reports on the stock. Evercore ISI lowered their price objective on shares of NXP Semiconductors from $240.00 to $235.00 in a […]

Source: wkrb13.com
Cantor Fitzgerald Reaffirms Overweight Rating for Novo Nordisk A/S (NYSE:NVO) - Vimarsana News

Cantor Fitzgerald Reaffirms Overweight Rating for Novo Nordisk A/S (NYSE:NVO)

Cantor Fitzgerald restated their overweight rating on shares of Novo Nordisk A/S (NYSE:NVO – Free Report) in a research report sent to investors on Monday, PriceTargets.com reports. Cantor Fitzgerald also issued estimates for Novo Nordisk A/S’s FY2023 earnings at $2.65 EPS and FY2024 earnings at $3.35 EPS. Other analysts have also issued research reports about […]

Ex-Ameriprise advisor Arthur S. Hoffman charged with fraud - Vimarsana News

Ex-Ameriprise advisor Arthur S. Hoffman charged with fraud

The advisor failed to disclose the low-interest loans he received from a fraudulent crypto securities issuer in exchange for selling the products, investigators say.